These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22253598)

  • 1. Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.
    Dupuy S; Lambert M; Zucman D; Choukem SP; Tognarelli S; Pages C; Lebbé C; Caillat-Zucman S
    PLoS Pathog; 2012 Jan; 8(1):e1002486. PubMed ID: 22253598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.
    Matthews NC; Goodier MR; Robey RC; Bower M; Gotch FM
    Eur J Immunol; 2011 Jul; 41(7):1958-68. PubMed ID: 21509779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
    Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
    Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of human herpes virus type 8-associated diseases by NK cells.
    Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
    Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma.
    Beldi-Ferchiou A; Lambert M; Dogniaux S; Vély F; Vivier E; Olive D; Dupuy S; Levasseur F; Zucman D; Lebbé C; Sène D; Hivroz C; Caillat-Zucman S
    Oncotarget; 2016 Nov; 7(45):72961-72977. PubMed ID: 27662664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.
    Rezza G; Andreoni M; Dorrucci M; Pezzotti P; Monini P; Zerboni R; Salassa B; Colangeli V; Sarmati L; Nicastri E; Barbanera M; Pristerà R; Aiuti F; Ortona L; Ensoli B
    J Natl Cancer Inst; 1999 Sep; 91(17):1468-74. PubMed ID: 10469747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.
    Alter G; Jost S; Rihn S; Reyor LL; Nolan BE; Ghebremichael M; Bosch R; Altfeld M; Lauer GM
    J Hepatol; 2011 Aug; 55(2):278-88. PubMed ID: 21168454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma.
    Lambert M; Gannagé M; Karras A; Abel M; Legendre C; Kerob D; Agbalika F; Girard PM; Lebbe C; Caillat-Zucman S
    Blood; 2006 Dec; 108(12):3871-80. PubMed ID: 16926293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do fewer cases of Kaposi's sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence?
    Reinheimer C; Allwinn R; Stürmer M
    Med Microbiol Immunol; 2011 Aug; 200(3):161-4. PubMed ID: 21336596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
    Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
    AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory KIR2DL2 receptor and HHV-8 in classic or endemic Kaposi sarcoma.
    Bortolotti D; Corazza M; Rotola A; Bencivelli D; Schiuma G; Danese E; Rizzo S; Beltrami S; Rizzo R; Borghi A
    Clin Exp Med; 2023 Feb; 23(1):79-85. PubMed ID: 35169985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.
    Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD
    Front Immunol; 2020; 11():40. PubMed ID: 32082316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complex.
    Renwick N; Weverling GJ; Halaby T; Portegies P; Bakker M; Schulz TF; Goudsmit J
    AIDS; 2001 Nov; 15(16):2165-9. PubMed ID: 11684936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.
    Hogan LE; Hanhauser E; Hobbs KS; Palmer CD; Robles Y; Jost S; LaCasce AS; Abramson J; Hamdan A; Marty FM; Kuritzkes DR; Henrich TJ
    PLoS One; 2018; 13(5):e0197298. PubMed ID: 29746555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Herpesvirus 6B Downregulates Expression of Activating Ligands during Lytic Infection To Escape Elimination by Natural Killer Cells.
    Schmiedel D; Tai J; Levi-Schaffer F; Dovrat S; Mandelboim O
    J Virol; 2016 Nov; 90(21):9608-9617. PubMed ID: 27535049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
    Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
    Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults.
    Nana BC; Esemu LF; Besong ME; Atchombat DHN; Ogai K; Sobgui TMP; Nana CMM; Seumko'o RMN; Awanakan H; Ekali GL; Leke RGF; Okamoto S; Ndhlovu LC; Megnekou R
    Front Immunol; 2023; 14():1216480. PubMed ID: 37809059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.